Discovering Hope Every Day
The Largest Phase 0 Clinical Trials Program in the World
The Ivy Brain Tumor Center is a nonprofit translational research program that offers state-of-the-art clinical trials for patients with even the most aggressive brain tumors.
Brain Tumor Treatment at Ivy
The Ivy Brain Tumor Center is a leader in brain tumor research and treatment. The Ivy Center is located in Phoenix, Arizona, at Barrow Neurological Institute, the highest-volume operative brain tumor center in the U.S.
Whether benign or malignant, a brain tumor can be life-changing. The Ivy Center’s multidisciplinary team of healthcare professionals and scientists work to understand the molecular structure of each patient’s brain tumor to determine its pathology and the most effective treatment plan. Explore a variety of brain tumor types we treat.
As one of the world’s largest brain tumor treatment centers, the Ivy Center utilizes advanced therapies, state-of-the-art technology and innovative clinical trials to tailor each patient’s treatment plan to their individualized needs and circumstances. No two brain tumors are alike and each tumor requires a treatment regimen designed for its unique genetic composition.
While each patient’s brain tumor experience is different, those on the receiving end of the diagnosis share the overwhelming feelings of worry, fear and stress. No one should have to cope with a brain cancer diagnosis alone. We understand the uncertainty of your circumstances. Our team is here for you every step of the way.
“At the Ivy Brain Tumor Center, you have people that take the time to study and research and they are committed to finding a cure for patients. It's a comfort to know that this institution is right here in my backyard.”
“When given an opportunity to participate in a clinical trial at the Ivy Brain Tumor Center – take it! Experimental clinical trials provide information that will eventually lead to a cure, and most importantly, they give HOPE!”
“The progress achieved by the Ivy Center’s Phase 0 clinical trials program has surpassed anything I have seen in the 16 years I have been funding brain cancer research. The new building in Phoenix will serve to leverage this success, so the Center can move even faster to discover and develop a new FDA-approved therapy for brain cancer.”
Ivy Brain Tumor Center clinical trials play a pivotal role in developing new therapies and advancing treatment options that make a significant impact on patient outcomes. The Ivy Center operates the world’s largest Phase 0 clinical trials program in the world.
Latest from Ivy
Gratitude is a powerful emotion. It has the ability to rewire the brain, creating new neural pathways, enhancing the production of serotonin and dopamine neurotransmitters and regulating stress hormones. Research suggests practicing gratitude can provide significant mental and physical benefits. Read our full blog post to get started practicing gratitude.
Ivy Brain Tumor Center Announces Promising Data for Niraparib in Phase 0/2 Glioblastoma Clinical Trial
The Ivy Brain Tumor Center at Barrow Neurological Institute announces promising results from a collaborative Phase 0/2 trial of niraparib, supported by GSK, in patients with newly diagnosed glioblastoma with unmethylated MGMT.
Discover the inspiring story of Wendy and Marty Kaye in our latest blog post. Motivated by their daughter Lauren’s battle with a brain tumor, the Kayes transformed their grief into action. They co-founded Students Supporting Brain Tumor Research (SSBTR), Arizona’s largest student-run nonprofit, dedicated to funding vital research and raising awareness. Read the full blog post.
Eileen Berger’s world changed drastically when her husband, Scott, had a severe seizure at night, leading to the discovery of a recurring brain tumor. Despite the ongoing anxiety and trauma, they learned to find comfort in gratitude, which transformed their outlook on life and helped them navigate their uncertain journey. Read more about Eileen’s story and how she manages brain cancer as a caregiver.
Exploring brain tumor treatments online can be overwhelming. From FDA-approved medications to clinical trials, the rapidly evolving landscape can leave patients feeling adrift and anxious about keeping pace with the latest advancements. Dr. Sanai shared essential tips and tools to decipher these options in his talk at the 2023 ABTA National Conference. We break it down for you in this blog post.